Global Tumor NGS Detection Kit Supply, Demand and Key Producers, 2023-2029
The global Tumor NGS Detection Kit market size is expected to reach $ 2446.3 million by 2029, rising at a market growth of 15.3% CAGR during the forecast period (2023-2029).
Tumor NGS detection kit is an experimental consumable used in tumor detection
This report studies the global Tumor NGS Detection Kit production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor NGS Detection Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor NGS Detection Kit that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor NGS Detection Kit total production and demand, 2018-2029, (K Units)
Global Tumor NGS Detection Kit total production value, 2018-2029, (USD Million)
Global Tumor NGS Detection Kit production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor NGS Detection Kit consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tumor NGS Detection Kit domestic production, consumption, key domestic manufacturers and share
Global Tumor NGS Detection Kit production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tumor NGS Detection Kit production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor NGS Detection Kit production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Tumor NGS Detection Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor NGS Detection Kit market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor NGS Detection Kit Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Tumor NGS Detection Kit Market, Segmentation by Type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
Global Tumor NGS Detection Kit Market, Segmentation by Application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Companies Profiled:
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O
Key Questions Answered
1. How big is the global Tumor NGS Detection Kit market?
2. What is the demand of the global Tumor NGS Detection Kit market?
3. What is the year over year growth of the global Tumor NGS Detection Kit market?
4. What is the production and production value of the global Tumor NGS Detection Kit market?
5. Who are the key producers in the global Tumor NGS Detection Kit market?
6. What are the growth factors driving the market demand?